LEXICON PHARMACEUTICALS, INC. Shareholders' Equity
LEXICON PHARMACEUTICALS, INC. (LXRX) had Shareholders' Equity of $174.53 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $174.53M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $202.86M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $107.54M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $120.16M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $174.53M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $202.86M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $107.54M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $120.16M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $129.44M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $123.03M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $145.95M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $178.51M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $239.98M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $288.87M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $93.11M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $139.51M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $186.36M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $88.05M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $117.12M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $144.02M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $70.83M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $92.70M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $113.59M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $136.60M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $137.23M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $152.55M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $156.37M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $87.64M 10-Q · filed 2020-10-30 | |
| 2020-06-30 | -$10.69M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $54.78M 10-Q · filed 2020-04-27 | |
| 2019-12-31 | $117.10M 10-K · filed 2023-03-03 | |
| 2019-09-30 | $164.71M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$64.89M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | -$45.69M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | -$26.41M 10-K · filed 2022-03-10 | |
| 2018-09-30 | -$29.40M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$5.07M 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $26.19M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $68.27M 10-K · filed 2021-03-12 | $52.10M 10-K · filed 2018-03-01 |
| 2017-09-30 | $78.38M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $106.31M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $134.60M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $167.51M 10-K · filed 2020-03-12 | $157.40M 10-K · filed 2017-03-06 |
| 2016-09-30 | $185.18M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $217.33M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $252.88M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $285.97M 10-K · filed 2019-03-15 | $285.85M 10-K · filed 2016-03-11 |
| 2015-09-30 | $197.94M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $231.47M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $257.61M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $284.02M 10-K · filed 2018-03-01 | |
| 2014-09-30 | $77.82M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $116.67M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $140.78M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $170.16M 10-K · filed 2017-03-06 | |
| 2013-09-30 | $185.71M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $215.08M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $242.21M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $266.68M 10-K · filed 2016-03-11 | |
| 2012-09-30 | $252.76M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $244.90M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $268.97M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $297.57M 10-K · filed 2015-03-12 | |
| 2011-09-30 | $169.48M 10-Q · filed 2011-11-01 | |
| 2011-06-30 | $194.19M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $247.02M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |